Medical Research
(H400)
IRS Verified
DX Registered
NATIONAL SCLERODERMA FOUNDATION
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$6.9M
Total Revenue
$6.5M
Total Expenses
$9.8M
Net Assets
33
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
73.5%
Fundraising Efficiency
0.0%
Operating Reserve
18.22x
Liability-to-Asset
23.9%
Revenue Diversification
87.6%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $6.9M | $6.5M | $9.8M | 73.5% | 33 |
| 2022 | $4.6M | $6.2M | N/A | — | 0 |
| 2021 | $4.2M | $4.5M | N/A | — | 24 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.